Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Postural Orthostatic Tachycardia Syndrome | 4 | 2024 | 52 | 3.210 |
Why?
|
Tilt-Table Test | 6 | 2024 | 80 | 2.780 |
Why?
|
Autonomic Nervous System Diseases | 5 | 2022 | 270 | 2.490 |
Why?
|
Orthostatic Intolerance | 4 | 2024 | 22 | 2.390 |
Why?
|
Autonomic Nervous System | 5 | 2022 | 707 | 1.570 |
Why?
|
Cerebrovascular Circulation | 13 | 2024 | 2725 | 1.570 |
Why?
|
Multiple System Atrophy | 6 | 2022 | 132 | 1.570 |
Why?
|
Heart Rate | 9 | 2024 | 4214 | 1.230 |
Why?
|
Mastocytosis | 4 | 2024 | 150 | 1.160 |
Why?
|
Blood Pressure | 12 | 2024 | 8543 | 0.960 |
Why?
|
Subthalamic Nucleus | 5 | 2011 | 203 | 0.930 |
Why?
|
Penicillanic Acid | 1 | 2024 | 41 | 0.900 |
Why?
|
Parkinson Disease | 9 | 2022 | 2893 | 0.890 |
Why?
|
Head-Down Tilt | 1 | 2023 | 67 | 0.880 |
Why?
|
Carbon Dioxide | 2 | 2024 | 1148 | 0.790 |
Why?
|
Syncope, Vasovagal | 1 | 2021 | 39 | 0.740 |
Why?
|
Primary Dysautonomias | 1 | 2021 | 28 | 0.740 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2021 | 62 | 0.730 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2021 | 109 | 0.710 |
Why?
|
Disaccharides | 1 | 2021 | 170 | 0.710 |
Why?
|
Valsalva Maneuver | 3 | 2021 | 99 | 0.650 |
Why?
|
Sweat Glands | 1 | 2019 | 33 | 0.630 |
Why?
|
Hypocapnia | 1 | 2018 | 38 | 0.630 |
Why?
|
Hypotension, Orthostatic | 1 | 2021 | 258 | 0.600 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 94 | 0.560 |
Why?
|
Insulin | 7 | 2023 | 6607 | 0.540 |
Why?
|
Skin Physiological Phenomena | 1 | 2017 | 193 | 0.540 |
Why?
|
Sweating | 1 | 2017 | 155 | 0.540 |
Why?
|
Deep Brain Stimulation | 5 | 2011 | 851 | 0.520 |
Why?
|
Tryptases | 3 | 2021 | 176 | 0.520 |
Why?
|
Galvanic Skin Response | 1 | 2017 | 359 | 0.500 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.440 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1892 | 0.420 |
Why?
|
Autoantibodies | 1 | 2021 | 2121 | 0.400 |
Why?
|
Mast Cells | 4 | 2024 | 1406 | 0.390 |
Why?
|
Administration, Intranasal | 6 | 2022 | 485 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 12252 | 0.310 |
Why?
|
Electrophysiology | 1 | 2011 | 1266 | 0.300 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 667 | 0.300 |
Why?
|
Dermis | 1 | 2008 | 203 | 0.280 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 2 | 2019 | 41 | 0.280 |
Why?
|
Action Potentials | 2 | 2011 | 1838 | 0.270 |
Why?
|
Reflex | 2 | 2021 | 375 | 0.250 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1613 | 0.240 |
Why?
|
Blood Flow Velocity | 6 | 2024 | 1375 | 0.240 |
Why?
|
Middle Cerebral Artery | 3 | 2024 | 271 | 0.240 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2024 | 277 | 0.230 |
Why?
|
Middle Aged | 41 | 2024 | 223492 | 0.220 |
Why?
|
Retrospective Studies | 12 | 2024 | 81762 | 0.220 |
Why?
|
Humans | 59 | 2024 | 768166 | 0.220 |
Why?
|
Hypoglycemic Agents | 5 | 2022 | 3109 | 0.200 |
Why?
|
Pilot Projects | 3 | 2023 | 8741 | 0.190 |
Why?
|
Biopsy | 3 | 2022 | 6793 | 0.190 |
Why?
|
Monitoring, Intraoperative | 2 | 2009 | 948 | 0.190 |
Why?
|
Dizziness | 1 | 2024 | 269 | 0.190 |
Why?
|
Aged | 29 | 2024 | 171504 | 0.170 |
Why?
|
Female | 40 | 2024 | 397192 | 0.170 |
Why?
|
Male | 40 | 2024 | 364719 | 0.170 |
Why?
|
Cerebral Infarction | 3 | 2010 | 969 | 0.160 |
Why?
|
Adult | 20 | 2024 | 223646 | 0.150 |
Why?
|
Syncope | 1 | 2021 | 430 | 0.150 |
Why?
|
Microelectrodes | 2 | 2011 | 305 | 0.150 |
Why?
|
Hand Strength | 1 | 2021 | 466 | 0.150 |
Why?
|
Duodenum | 1 | 2021 | 495 | 0.150 |
Why?
|
Double-Blind Method | 7 | 2023 | 12465 | 0.150 |
Why?
|
Neural Conduction | 2 | 2019 | 443 | 0.140 |
Why?
|
Vasoconstriction | 2 | 2011 | 592 | 0.140 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 849 | 0.140 |
Why?
|
Vasodilation | 2 | 2013 | 967 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 617 | 0.140 |
Why?
|
Posture | 3 | 2010 | 957 | 0.130 |
Why?
|
Functional Laterality | 3 | 2011 | 2264 | 0.130 |
Why?
|
Activities of Daily Living | 4 | 2015 | 2430 | 0.120 |
Why?
|
Brain | 8 | 2022 | 27360 | 0.120 |
Why?
|
Serine | 1 | 2019 | 831 | 0.120 |
Why?
|
Postural Balance | 2 | 2010 | 639 | 0.120 |
Why?
|
Fatigue | 1 | 2022 | 1557 | 0.120 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2016 | 254 | 0.110 |
Why?
|
Electroencephalography | 2 | 2007 | 6314 | 0.110 |
Why?
|
Anaphylaxis | 1 | 2021 | 758 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1206 | 0.100 |
Why?
|
Memory | 2 | 2020 | 2208 | 0.100 |
Why?
|
Single-Blind Method | 2 | 2016 | 1587 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2015 | 753 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1887 | 0.090 |
Why?
|
Stereotaxic Techniques | 2 | 2009 | 553 | 0.080 |
Why?
|
Atrophy | 2 | 2011 | 1646 | 0.080 |
Why?
|
Stroke | 5 | 2015 | 9755 | 0.080 |
Why?
|
Huntington Disease | 1 | 2016 | 1147 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2018 | 22291 | 0.080 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1703 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 10 | 2014 | 36743 | 0.080 |
Why?
|
Sympathetic Nervous System | 1 | 2011 | 521 | 0.080 |
Why?
|
Disability Evaluation | 2 | 2012 | 1835 | 0.070 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2008 | 199 | 0.070 |
Why?
|
Neurons | 1 | 2007 | 9514 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2009 | 2593 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2744 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 407 | 0.060 |
Why?
|
Electromyography | 1 | 2011 | 1401 | 0.060 |
Why?
|
Genetic Variation | 1 | 2021 | 6611 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26379 | 0.060 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 486 | 0.060 |
Why?
|
Brain Mapping | 2 | 2011 | 6685 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2420 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1489 | 0.060 |
Why?
|
Brain Infarction | 2 | 2003 | 286 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20227 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2022 | 59629 | 0.050 |
Why?
|
Preoperative Care | 2 | 2009 | 2258 | 0.050 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 635 | 0.050 |
Why?
|
Prospective Studies | 5 | 2020 | 54926 | 0.050 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 952 | 0.050 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2003 | 58 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2005 | 449 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 65371 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10399 | 0.050 |
Why?
|
Tachycardia | 1 | 2005 | 599 | 0.050 |
Why?
|
Cognition | 3 | 2020 | 7073 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3785 | 0.050 |
Why?
|
Benzazepines | 1 | 2023 | 308 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4503 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15948 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2022 | 312 | 0.040 |
Why?
|
Hypertension | 3 | 2008 | 8616 | 0.040 |
Why?
|
Florida | 1 | 2021 | 417 | 0.040 |
Why?
|
Disease Progression | 2 | 2015 | 13671 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3858 | 0.040 |
Why?
|
Anti-Allergic Agents | 1 | 2021 | 156 | 0.040 |
Why?
|
Urticaria | 1 | 2021 | 151 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11879 | 0.040 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2019 | 42 | 0.040 |
Why?
|
Ossification, Heterotopic | 1 | 2001 | 240 | 0.040 |
Why?
|
Research Design | 2 | 2020 | 6211 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3272 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1082 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2005 | 841 | 0.040 |
Why?
|
Sphingolipids | 1 | 2019 | 178 | 0.030 |
Why?
|
Hemodynamics | 1 | 2007 | 4194 | 0.030 |
Why?
|
Eating | 1 | 2023 | 1542 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2022 | 773 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4413 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 465 | 0.030 |
Why?
|
Image Enhancement | 2 | 2005 | 2880 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2872 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 2 | 2013 | 1429 | 0.030 |
Why?
|
Brain Ischemia | 2 | 2009 | 3007 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1737 | 0.030 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2015 | 102 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2015 | 151 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39348 | 0.030 |
Why?
|
Body Composition | 1 | 2023 | 2462 | 0.030 |
Why?
|
Animals | 3 | 2024 | 169246 | 0.030 |
Why?
|
Parkinsonian Disorders | 1 | 2015 | 285 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8054 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14783 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 13053 | 0.020 |
Why?
|
Acceleration | 1 | 2011 | 189 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3044 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2009 | 15832 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2011 | 493 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3583 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9374 | 0.020 |
Why?
|
Atlases as Topic | 1 | 2009 | 248 | 0.020 |
Why?
|
Neuronavigation | 1 | 2009 | 168 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 948 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9384 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 252 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6430 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 482 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 60066 | 0.020 |
Why?
|
Cerebrum | 1 | 2008 | 132 | 0.020 |
Why?
|
Levodopa | 1 | 2007 | 221 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2007 | 184 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 13090 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 89169 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3327 | 0.020 |
Why?
|
Cerebellar Diseases | 1 | 2007 | 227 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2008 | 939 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 799 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2009 | 836 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2267 | 0.010 |
Why?
|
Sample Size | 1 | 2007 | 846 | 0.010 |
Why?
|
Gait | 1 | 2009 | 823 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 1997 | 0.010 |
Why?
|
Hyperventilation | 1 | 2003 | 78 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16726 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 41754 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2003 | 9118 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
Visual Perception | 1 | 2010 | 1402 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7140 | 0.010 |
Why?
|
Artifacts | 1 | 2009 | 1926 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2118 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 2002 | 550 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2862 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18065 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2002 | 553 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2009 | 2650 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3436 | 0.010 |
Why?
|
Respiration | 1 | 2005 | 1665 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42669 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 2001 | 646 | 0.010 |
Why?
|
Microcirculation | 1 | 2002 | 1281 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2001 | 942 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7852 | 0.010 |
Why?
|
Calcinosis | 1 | 2001 | 1481 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 9015 | 0.010 |
Why?
|
Child | 1 | 2021 | 80917 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2009 | 20760 | 0.010 |
Why?
|
Contrast Media | 1 | 2005 | 5330 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30238 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2002 | 2655 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 8509 | 0.010 |
Why?
|
Ultrasonography | 1 | 2001 | 6004 | 0.000 |
Why?
|
United States | 1 | 2015 | 73039 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40218 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74944 | 0.000 |
Why?
|